fluconazole has been researched along with Diabetic Foot in 5 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Diabetic Foot: Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that fluconazole plus standard care is superior to the standard care for diabetic foot wounds infected with deep-seated fungal infections." | 5.16 | Targeted treatment of invasive fungal infections accelerates healing of foot wounds in patients with Type 2 diabetes. ( Bal, A; Chellan, G; Dinesh, KR; Jayakumar, RV; Kumar, H; Mangalanandan, TS; Neethu, K; Shashikala, S; Sundaram, KR; Varma, AK; Varma, N, 2012) |
| "In the treatment of onychomycosis, compliance and drug interactions are important considerations, as diabetic patients frequently take concomitant medications." | 2.45 | Toenail onychomycosis in diabetic patients: issues and management. ( Budihardja, D; Freund, V; Mayser, P, 2009) |
| "diabetic foot ulcer is the leading cause of hospital admissions, lower limb amputation and death among diabetic patients." | 1.72 | Speciation and antifungal susceptibility of ( Masika, MM; Musyoki, VM; Mutai, W; Ngugi, N; Otieno, F, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musyoki, VM | 1 |
| Mutai, W | 1 |
| Ngugi, N | 1 |
| Otieno, F | 1 |
| Masika, MM | 1 |
| Townsend, EM | 1 |
| Sherry, L | 1 |
| Kean, R | 1 |
| Hansom, D | 1 |
| Mackay, WG | 1 |
| Williams, C | 1 |
| Butcher, J | 1 |
| Ramage, G | 1 |
| Torrence, GM | 1 |
| Schmidt, BM | 1 |
| Mayser, P | 1 |
| Freund, V | 1 |
| Budihardja, D | 1 |
| Chellan, G | 1 |
| Neethu, K | 1 |
| Varma, AK | 1 |
| Mangalanandan, TS | 1 |
| Shashikala, S | 1 |
| Dinesh, KR | 1 |
| Sundaram, KR | 1 |
| Varma, N | 1 |
| Jayakumar, RV | 1 |
| Bal, A | 1 |
| Kumar, H | 1 |
1 review available for fluconazole and Diabetic Foot
| Article | Year |
|---|---|
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes | 2009 |
1 trial available for fluconazole and Diabetic Foot
| Article | Year |
|---|---|
Targeted treatment of invasive fungal infections accelerates healing of foot wounds in patients with Type 2 diabetes.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Blood Glucose; Case-Control St | 2012 |
3 other studies available for fluconazole and Diabetic Foot
| Article | Year |
|---|---|
Speciation and antifungal susceptibility of
Topics: Adult; Antifungal Agents; Candida; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Foot | 2022 |
Implications of Antimicrobial Combinations in Complex Wound Biofilms Containing Fungi.
Topics: Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Ciprofloxacin; Diabetic Foot; | 2017 |
Fungal Osteomyelitis in Diabetic Foot Infections: A Case Series and Comparative Analysis.
Topics: Aged; Antifungal Agents; Biopsy; Bone and Bones; Candida; Dermatomycoses; Diabetes Mellitus, Type 2; | 2018 |